Insulin-like growth factor I in relation to prostate cancer and benign prostatic hyperplasia
1998

Insulin-like Growth Factor I and Prostate Cancer

publication Evidence: moderate

Author Information

Author(s): P Cohen, D M Peehl, R Rosenfeld

Primary Institution: Children's Hospital of Philadelphia, University of Pennsylvania

Hypothesis

Serum insulin-like growth factor 1 (IGF-1) levels are elevated in prostate cancer patients.

Conclusion

The study suggests that there is no relationship between circulating IGF-1 levels and the prevalence of prostate cancer.

Supporting Evidence

  • Previous studies showed normal IGF-1 levels in prostate cancer patients.
  • Elevated IGFBP-2 levels were found in prostate cancer patients.
  • IGFBP-2 and IGFBP-4 were not removed by the assay method used in the study.

Takeaway

Doctors thought that a hormone called IGF-1 might be linked to prostate cancer, but this study shows that it isn't.

Methodology

The study involved comparing serum IGF-1 and IGFBP levels in prostate cancer patients and age-matched controls.

Potential Biases

Potential bias due to reliance on existing assays that may not accurately measure IGF levels.

Limitations

The study relies on previously published data and does not present new experimental results.

Participant Demographics

Prostate cancer patients and age-matched controls.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication